GlassScriptPhysician profile
Todd Alan Honea
NPI 1669560884
$4,085.94
in general payments reported to CMS, 2019-2025
9 companies · $345 in 2025
The $345 reported for 2025 was more than what 86% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $876 · 2021: $13.43 · 2023: $2,100 · 2024: $227 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,469 · Gift: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.54 |
| Gift | $203.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivoclar Vivadent, INC. | $1,867.41 | 2023 | |
| Straumann USA LLC | $1,401.42 | 2019-2021 | |
| Patterson Companies, INC. | $355.98 | 2024-2025 | |
| Ultradent Products INC | $228.61 | 2019-2025 | Opalescence |
| Align Technology, INC. | $55.55 | 2023 | Itero Element Flex, Itero Element 5d Plus |
| Zimvie INC. | $46.78 | 2023 | |
| Dentsply Sirona INC | $44.33 | 2023 | Cerec, Tph Spectra Universal Composite Restorative Low Viscosity |
| Ormco Corporation | $42.93 | 2023 | Kavo Op300 |
| Nobel Biocare USA | $42.93 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Honea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.